Abstract
PPARs and Liver Disease
Highlights
nonalcoholic fatty liver diseases (NAFLDs), a major cause of progressive liver disease, is increasing worldwide at an alarming rate
Peroxisome proliferation-activated receptors (PPARs) were considered target molecules of human metabolic disease such as nonalcoholic fatty liver diseases (NAFLDs) including nonalcoholic steatohepatitis (NASH), a condition that might progress to cirrhosis
We summarize the relevance of PPARs and hepatocellular carcinoma (HCC) including cancer stem cells. ese ve articles have interesting and valuable points of views regarding PPARs and liver diseases
Summary
NAFLD, a major cause of progressive liver disease, is increasing worldwide at an alarming rate. Yasuteru Kondo,1 Kenji Uno,2 Keigo Machida,3 and Masanori Terajima4 Is special issue of PPAR Research contains four interesting reviews and a research article examining the relevance of PPARs to liver diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have